About Biosettia
Biosettia is a Healthcare company based in San Diego (United States) founded in 2006. Molecular biology products and services for genome analysis are provided. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Suite. Its competitors include Avidity Biosciences, Arbor Biotechnologies and Sutro Biopharma; 3 of its 3 listed competitors have raised funding.
Company details
Biosettia was founded in 2006 and is based in San Diego, United States. Operations center on the molecular biology sector, where tools and specialty reagents are developed for genome-wide functional analysis and induced pluripotent stem cell generation. Offerings include single-strand RNAi technology, microRNA expression systems, normalized full-length cDNA libraries, and lentiviral delivery systems to support research needs.
- Headquarters San Diego, United States
- SectorsHealthcare
- Website biosettia.com
- Social LinkedIn
- Latest Funding Round$99.95K (USD), Grant
May 2010
- Investors
Funding Insights of Biosettia
- Total Rounds 1
- Last Round Grant — $99,954
- First Round $99,954
(May 2010)
- Investors Count 1
All 1 funding rounds of Biosettia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2010 | $99,954 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Biosettia
Biosettia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Biosettia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biosettia
2 dated milestones of Biosettia across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Biosettia is founded.
- Funding First funding round of $100K.
Competitors of Biosettia
Biosettia has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Arbor Biotechnologies and Sutro Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed competitors of Biosettia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biosettia
The website of Biosettia (biosettia.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 231.3% vs previous month
Websites whose visitors overlap most with Biosettia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tiger-aesthetics.com | tiger-aesthetics.com | 100% | #3,583,261 | – | |
| alfascientific.com | 100% | #8,547,751 | View details | ||
| truvianhealth.com | 100% | 4.2K | #4,492,336 | View details | |
medsalesinstitute.com | medsalesinstitute.com | 99% | #8,826,142 | – | |
kadencehealthcare.com | kadencehealthcare.com | 99% | #7,313,283 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Biosettia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biosettia (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biosettia
Biosettia was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Biosettia is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Biosettia was founded in 2006 and is based in San Diego, United States. Operations center on the molecular biology sector, where tools and specialty reagents are developed for genome-wide functional analysis and induced pluripotent stem cell generation. Offerings include single-strand RNAi technology, microRNA expression systems, normalized full-length cDNA libraries, and lentiviral delivery systems to support research needs.
Biosettia's top competitors include Sutro Biopharma, Avidity Biosciences and Arbor Biotechnologies.
Biosettia has 1 investor. Key investors include HHS.